Status:
COMPLETED
Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the evolution of the impact on daily life activities over the first 12 months following the introduction of interferon beta-1b treatment in patients presenting RRMS or patients at high ris...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Males or females aged 18 years or over, having received a confirmed diagnosis of RRMS as defined by the MacDonald or Poser criteria or after a first clinical demyelinating event suggestive of Multiple Sclerosis, and meeting the requirements of the study inclusion criteria
- The choice of treatment must be clearly dissociated from the decision to include the patient in the study.
Exclusion
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00928967
Start Date
May 1 2007
End Date
November 1 2010
Last Update
October 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, France